Cargando…
Use of mesenchymal stem cell therapy in COVID-19 related strokes
Coronavirus disease 2019 (COVID-19) has affected a broad demographics, eliciting a more significant effect on specific groups such as males, African Americans, and Hispanic minorities. Treatment of COVID-19 often requires antiviral drugs or monoclonal antibodies. However, immunotherapies such as mes...
Autores principales: | Rawat, Mahika, Ng, Chiao, Khan, Emaad, Shah, Rayyan A., Ashfaq, Suha, Bahader, Ghaith A., Shah, Zahoor A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10233790/ https://www.ncbi.nlm.nih.gov/pubmed/36926703 http://dx.doi.org/10.4103/1673-5374.367927 |
Ejemplares similares
-
Cofilin Inhibitor Protects against Traumatic Brain Injury-Induced Oxidative Stress and Neuroinflammation
por: Bahader, Ghaith A., et al.
Publicado: (2023) -
Perspective on the relationship between microbiota dysbiosis and neuroinflammation: probiotics as a treatment option
por: Ng, Chiao W., et al.
Publicado: (2022) -
Withania somnifera: a pre-clinical study on neuroregenerative therapy for stroke
por: Raghavan, Aparna, et al.
Publicado: (2015) -
Small interfering RNAs based therapies for intracerebral hemorrhage: challenges and progress in drug delivery systems
por: Almarghalani, Daniyah A., et al.
Publicado: (2022) -
Progress in Mesenchymal Stem Cell Therapy for Ischemic Stroke
por: Guo, Yinghan, et al.
Publicado: (2021)